Study Site 29 — Anniston, Alabama

Study Site 29 is a clinical research site located in Anniston, Alabama, United States 36207.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Study Site 29 has participated in 1 clinical trials.

Therapeutic areas: Diabetes Mellitus, Type 2.

Sponsors: NovMetaPharma Co., Ltd..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Anniston

Browse all research sites in Alabama · View every site in Anniston

• Pinnacle Research Group
• Northeast Alabama Regional Medical Center
• Research Site
• GSK Investigational Site
• Novartis Investigative Site
• Regional Medical Center
• Pfizer Investigational Site
• Novo Nordisk Investigational Site
• Local Institution
• Pinnacle Research Group; Llc, Central
• Investigational Site Number 840070
• Anniston Medical Clinic

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Study Site 29?

Study Site 29 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Study Site 29 conducted?

Study Site 29 has 1 clinical trials on record. Their work covers Diabetes Mellitus, Type 2.

Is Study Site 29 accredited by Crixeo Clinical Trials?

Study Site 29 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Study Site 29?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.